FMII
FOLD

Farmers & Merchants Investments Inc’s Amicus Therapeutics FOLD Stock Holding History

Farmers & Merchants Investments Inc’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-313
Closed -$3K – 950
2021
Q1 		$3K Hold
313
– – ﹤0.01% 814
2020
Q4 		$7K Hold
313
– – ﹤0.01% 692
2020
Q3 		$4K Buy
+313
New +$4.56K ﹤0.01% 746

Other funds holding FOLD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Farmers & Merchants Investments Inc's FOLD Position: Q2 2021 in Review

Farmers & Merchants Investments Inc sold out of Amicus Therapeutics (FOLD) in Q2 2021, closing a stake of 313 shares — an estimated $3K sold.

Farmers & Merchants Investments Inc first reported a position in FOLD in Q3 2020 and held it in 3 quarters. The position peaked at $7K in Q4 2020. 235 funds tracked by Wall St. Rank hold FOLD as of Q2 2021.

  • Farmers & Merchants Investments Inc reported no remaining Amicus Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Farmers & Merchants Investments Inc sold 313 Amicus Therapeutics shares in Q2 2021, an estimated $3K.
  • Farmers & Merchants Investments Inc first reported a position in Amicus Therapeutics in Q3 2020 and held it in 3 quarters.
  • Farmers & Merchants Investments Inc's Amicus Therapeutics position peaked at $7K in Q4 2020.
  • 235 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2021.

Based on Farmers & Merchants Investments Inc's 13F filing for Q2 2021, filed 16 Jul 2021.